Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients

Clinical Transplantation

Volumn 21, Issue 5, 2007, Pages 638-642

  Matsuno, Naoto ^a   Nakamura, Yuki ^a   Mejit, Abudushukur ^a   Hama, Koichiro ^a   Iwamoto, Hitoshi ^a   Konno, Osamu ^a   Jojima, Yoshimaro ^a   Akashi, Isao ^a   Iwahori, Tohru ^a   Ashizawa, Tatsuhito ^a   Nagao, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

ABO incompatible; Adult liver transplantation; Cirrhotic patients; Plasmapheresis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFAMSTAT MESILATE; PROSTAGLANDIN E1; STEROID; TACROLIMUS;

ADULT; ANTICOAGULATION; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; CASE REPORT; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART INFARCTION; HEMATOMA; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; SURGICAL DRAINAGE; VEIN THROMBOSIS; WILSON DISEASE;

ABO BLOOD-GROUP SYSTEM; ADULT; ALPROSTADIL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMAPHERESIS; SPLENECTOMY; STEROIDS; SURVIVORS;

EID: 34548651473     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00702.x     Document Type: Article

References (12)

1. Demetris AJ, Jaffe R, Tzakis A et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988: 132: 489.
2. Gugenheim J, Samuel D, Reynes M, B ismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990: 336: 519.
3. Farges O, Kalil AN, Samuel D et al. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients. Transplantation 1995: 59: 1124.
4. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 2005: 19: 76.
5. Tanabe K, Takahashi K, Sonda K et al. Long-term results of ABO-incompatible living kidney transplantation: A single-center experience. Transplantation 1998: 65: 224.
6. S inmmura H, T anabe K, I shikawa N et al. Role of anti-A/B antibody in results of ABO-incompatible kidney transplantation. Transplantation 2000: 70: 1331.
7. Ishida H, Tanabe K, Toma H et al. Therapeutic apheresis therapy for ABO-incompatible renal transplantation. Therapeutic Apheresis and Dialysis 2003: 7: 520.
8. Takahashi K. A new immunosuppressive therapy in ABO-incompatible kidney transplantation based on a new concept of accommodation. In: T akahashi K, ed. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier BV, 2006: 73.
9. Tanabe M, Shimazu M, Wakabayashi G et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002: 73: 1959.
10. Oike F, Kamei H, Tanaka K. Novel approaches for ABO blood-type incompatible liver transplantation from living donor: Intraportal infusion therapy and hepatic arterial infusion therapy. Konnichi No Ishoku 2003: 16: 479.
11. Hanto DW, Fecteau AH, Alonso MH et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003: 9: 22.
12. Takaya S, Iwaki Y, Starzl TE. Liver transplantation in positive cytotoxic crossmatch case using FK506, high-dose steroids, and prostaglandin E. Transplantation 1992: 54: 927.